S&P 500   4,957.13 (-1.08%)
DOW   37,869.42 (+0.25%)
QQQ   415.59 (-1.85%)
AAPL   165.04 (-1.20%)
MSFT   399.88 (-1.09%)
META   482.06 (-3.93%)
GOOGL   153.91 (-1.35%)
AMZN   174.56 (-2.60%)
TSLA   147.73 (-1.47%)
NVDA   782.23 (-7.62%)
AMD   147.03 (-5.19%)
NIO   3.82 (-4.50%)
BABA   68.94 (+0.09%)
T   16.48 (+0.92%)
F   12.09 (+0.25%)
MU   106.86 (-4.53%)
GE   148.58 (-2.85%)
CGC   8.06 (+2.94%)
DIS   112.30 (-0.12%)
AMC   3.19 (+9.25%)
PFE   25.90 (+2.01%)
PYPL   62.02 (-0.13%)
XOM   119.91 (+1.17%)
S&P 500   4,957.13 (-1.08%)
DOW   37,869.42 (+0.25%)
QQQ   415.59 (-1.85%)
AAPL   165.04 (-1.20%)
MSFT   399.88 (-1.09%)
META   482.06 (-3.93%)
GOOGL   153.91 (-1.35%)
AMZN   174.56 (-2.60%)
TSLA   147.73 (-1.47%)
NVDA   782.23 (-7.62%)
AMD   147.03 (-5.19%)
NIO   3.82 (-4.50%)
BABA   68.94 (+0.09%)
T   16.48 (+0.92%)
F   12.09 (+0.25%)
MU   106.86 (-4.53%)
GE   148.58 (-2.85%)
CGC   8.06 (+2.94%)
DIS   112.30 (-0.12%)
AMC   3.19 (+9.25%)
PFE   25.90 (+2.01%)
PYPL   62.02 (-0.13%)
XOM   119.91 (+1.17%)
S&P 500   4,957.13 (-1.08%)
DOW   37,869.42 (+0.25%)
QQQ   415.59 (-1.85%)
AAPL   165.04 (-1.20%)
MSFT   399.88 (-1.09%)
META   482.06 (-3.93%)
GOOGL   153.91 (-1.35%)
AMZN   174.56 (-2.60%)
TSLA   147.73 (-1.47%)
NVDA   782.23 (-7.62%)
AMD   147.03 (-5.19%)
NIO   3.82 (-4.50%)
BABA   68.94 (+0.09%)
T   16.48 (+0.92%)
F   12.09 (+0.25%)
MU   106.86 (-4.53%)
GE   148.58 (-2.85%)
CGC   8.06 (+2.94%)
DIS   112.30 (-0.12%)
AMC   3.19 (+9.25%)
PFE   25.90 (+2.01%)
PYPL   62.02 (-0.13%)
XOM   119.91 (+1.17%)
S&P 500   4,957.13 (-1.08%)
DOW   37,869.42 (+0.25%)
QQQ   415.59 (-1.85%)
AAPL   165.04 (-1.20%)
MSFT   399.88 (-1.09%)
META   482.06 (-3.93%)
GOOGL   153.91 (-1.35%)
AMZN   174.56 (-2.60%)
TSLA   147.73 (-1.47%)
NVDA   782.23 (-7.62%)
AMD   147.03 (-5.19%)
NIO   3.82 (-4.50%)
BABA   68.94 (+0.09%)
T   16.48 (+0.92%)
F   12.09 (+0.25%)
MU   106.86 (-4.53%)
GE   148.58 (-2.85%)
CGC   8.06 (+2.94%)
DIS   112.30 (-0.12%)
AMC   3.19 (+9.25%)
PFE   25.90 (+2.01%)
PYPL   62.02 (-0.13%)
XOM   119.91 (+1.17%)

Hookipa Pharma (HOOK) News Today

$0.74
-0.02 (-3.14%)
(As of 02:34 PM ET)
SourceHeadline
finanznachrichten.de logoHOOKIPA Pharma Inc.: HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
finanznachrichten.de - April 17 at 10:29 AM
finance.yahoo.com logoHOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - April 16 at 6:51 PM
MarketBeat logoHookipa Pharma Inc (NASDAQ:HOOK) Short Interest Down 5.2% in March
americanbankingnews.com - April 16 at 2:30 AM
globenewswire.com logoHOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration
globenewswire.com - April 10 at 7:01 AM
marketbeat.com logoHookipa Pharma Inc (NASDAQ:HOOK) Sees Significant Growth in Short Interest
marketbeat.com - April 1 at 8:36 PM
markets.businessinsider.com logoOptimistic Buy Rating for Hookipa Pharma Based on Promising HB-200 Trial Results and Strategic Trial Design
markets.businessinsider.com - March 27 at 8:50 AM
marketbeat.com logoHookipa Pharma Inc (NASDAQ:HOOK) Expected to Post FY2028 Earnings of $0.31 Per Share
marketbeat.com - March 26 at 8:26 AM
marketbeat.com logoHookipa Pharma's (HOOK) "Outperform" Rating Reaffirmed at Royal Bank of Canada
marketbeat.com - March 25 at 12:19 PM
finanznachrichten.de logoHOOKIPA Pharma Inc.: HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
finanznachrichten.de - March 24 at 5:14 PM
finance.yahoo.com logoTime To Worry? Analysts Just Downgraded Their HOOKIPA Pharma Inc. (NASDAQ:HOOK) Outlook
finance.yahoo.com - March 24 at 9:19 AM
benzinga.com logoHOOKIPA Pharma Stock (NASDAQ:HOOK), Earnings Estimates, EPS, and Revenue
benzinga.com - March 23 at 4:51 AM
markets.businessinsider.com logoBuy Rating Affirmed for Hookipa Pharma on Emerging Oncology and Infectious Disease Pipelines
markets.businessinsider.com - March 23 at 4:51 AM
msn.com logoHOOKIPA Pharma GAAP EPS of -$0.22 misses by $0.02, revenue of $7.41M beats by $2.85M
msn.com - March 22 at 9:18 AM
globenewswire.com logoHOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
globenewswire.com - March 22 at 7:01 AM
globenewswire.com logoHOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference
globenewswire.com - March 6 at 7:01 AM
marketbeat.com logoHookipa Pharma (NASDAQ:HOOK) Stock Price Down 4%
marketbeat.com - March 1 at 2:20 AM
morningstar.com logoHOOKIPA Pharma Inc HOOK
morningstar.com - February 28 at 7:29 PM
benzinga.com logoHOOKIPA Pharma Stock (NASDAQ:HOOK) Dividends: History, Yield and Dates
benzinga.com - February 22 at 8:00 AM
finance.yahoo.com logoAll You Need to Know About HOOKIPA Pharma Inc. (HOOK) Rating Upgrade to Strong Buy
finance.yahoo.com - February 2 at 2:50 PM
markets.businessinsider.com logoMaintaining Buy Rating on Hookipa Pharma Amid Strategic Repositioning and Pipeline Promise
markets.businessinsider.com - February 1 at 8:55 AM
marketbeat.com logoHookipa Pharma Inc (NASDAQ:HOOK) Forecasted to Post FY2024 Earnings of ($0.27) Per Share
marketbeat.com - February 1 at 6:30 AM
uk.investing.com logoHookipa Pharma Inc (HOOK)
uk.investing.com - January 31 at 9:43 AM
marketbeat.com logoRoyal Bank of Canada Lowers Hookipa Pharma (NASDAQ:HOOK) Price Target to $5.00
marketbeat.com - January 30 at 10:23 AM
markets.businessinsider.com logoStrategic Focus on Promising HPV+ Cancer Candidate Underpins Buy Rating for Hookipa Pharma
markets.businessinsider.com - January 29 at 7:39 PM
markets.businessinsider.com logoHOOKIPA Pharma To Cut Jobs Following Collaboration Termination By Roche
markets.businessinsider.com - January 29 at 2:38 PM
msn.com logoRoche Walks Away From HOOKIPA Pharma-Partnered KRAS-Focused Cancer Deal
msn.com - January 29 at 2:38 PM
marketwatch.com logoHOOKIPA Pharma Shares Fall Premarket as Roche Ends Collaboration
marketwatch.com - January 29 at 9:37 AM
finanznachrichten.de logoHOOKIPA Pharma Inc.: HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization
finanznachrichten.de - January 16 at 9:02 AM
finance.yahoo.com logoHOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization
finance.yahoo.com - January 16 at 9:02 AM
finance.yahoo.com logoHOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization
finance.yahoo.com - January 16 at 9:02 AM
finanznachrichten.de logoHOOKIPA Pharma Inc.: HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences
finanznachrichten.de - December 22 at 12:42 PM
msn.com logoHOOKIPA Pharma files to sell 15M shares for holders
msn.com - December 22 at 12:42 PM
ca.finance.yahoo.com logoHOOKIPA Pharma Inc. (HOOK)
ca.finance.yahoo.com - December 22 at 7:41 AM
marketwatch.com logoHOOKIPA Pharma Shares Soar After Gilead Sciences Investment
marketwatch.com - December 21 at 10:16 AM
finance.yahoo.com logoHOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences
finance.yahoo.com - December 21 at 10:16 AM
investorplace.com logoWhy Is Hookipa Pharma (HOOK) Stock Up 81% Today?
investorplace.com - December 21 at 10:00 AM
markets.businessinsider.com logoHOOKIPA Pharma: HB-500 IND Application Gets FDA Clearance To Treat HIV
markets.businessinsider.com - November 20 at 10:02 AM
finance.yahoo.com logoHOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-500 for the Treatment of Human Immunodeficiency Virus
finance.yahoo.com - November 20 at 10:02 AM
markets.businessinsider.com logoPromising Clinical Trials and Strong Financial Performance Bolster Buy Rating for Hookipa Pharma
markets.businessinsider.com - November 12 at 12:31 AM
markets.businessinsider.com logoHOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
markets.businessinsider.com - November 10 at 12:24 AM
finanznachrichten.de logoHOOKIPA Pharma Inc.: HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
finanznachrichten.de - November 9 at 1:52 PM
msn.com logoHOOKIPA Pharma GAAP EPS of -$0.17 beats by $0.03, revenue of $6.87M beats by $2.62M
msn.com - November 9 at 1:52 PM
finance.yahoo.com logoHOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
finance.yahoo.com - November 9 at 8:52 AM
finance.yahoo.com logoHOOKIPA Pharma Inc. Reports Increased Revenue and Higher R&D Expenses in Q3 2023
finance.yahoo.com - November 9 at 8:52 AM
finance.yahoo.com logoHOOKIPA Pharma Presents Positive Biomarker and Translational Data on HB-200 Monotherapy at Society for Immunotherapy of Cancer 2023
finance.yahoo.com - November 3 at 2:23 PM
finance.yahoo.com logoHOOKIPA Pharma to Report Third Quarter 2023 Financial Results and Recent Business Highlights on November 9, 2023
finance.yahoo.com - November 2 at 6:56 PM
finance.yahoo.com logoHOOKIPA Pharma Presents Additional Preliminary Phase 2 Data on HB-200 in Combination with Pembrolizumab as First-Line Treatment in Patients with HPV16+ Head and Neck Cancers at European Society for Medical Oncology Congress 2023
finance.yahoo.com - October 22 at 8:19 AM
finance.yahoo.com logoHOOKIPA Pharma announces publication of preclinical data of hepatitis B virus (HBV) therapeutic vaccine developed in collaboration with Gilead Sciences
finance.yahoo.com - October 18 at 7:40 AM
markets.businessinsider.com logoAnalyst Ratings for HOOKIPA Pharma
markets.businessinsider.com - September 27 at 4:46 PM
markets.businessinsider.com logoRBC Capital Keeps Their Buy Rating on Hookipa Pharma (HOOK)
markets.businessinsider.com - September 27 at 11:46 AM
Get Hookipa Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for HOOK and its competitors with MarketBeat's FREE daily newsletter.

Strange new buyer driving up gold (Ad)

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

HOOK Media Mentions By Week

HOOK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HOOK
News Sentiment

1.56

0.52

Average
Medical
News Sentiment

HOOK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HOOK Articles
This Week

4

1

HOOK Articles
Average Week

Get Hookipa Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for HOOK and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:HOOK) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners